Article
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Rating:
0.0
Views:
69
Likes:
1
Library:
1
Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a midstage trial, the companies reported on Monday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value